Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: FOSUN PHARMA(02196) the Revenue is 11.97 B (+9.28%), Miss estimate;the EBIT is 1.432 B (+37.97%), Beat estimate;the EPS is 0.369 (-3.59%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
11.97B9.28%
12.30B12.31%
-0.33B3.03%
EBITExceed expectations
1.43B37.97%
1.11B6.65%
+0.33B31.32%
EPSMiss expectations
0.36933.59%
0.40976.95%
-0.040410.54%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf